Cheryl Scott

1 month ago | bioprocessintl.com | Cheryl Scott |Olena Chervonenko |Mike King |Philip Johnson

In nearly 30 years of working as an editor covering the biopharmaceutical industry, first with BioPharm and later as cofounder of BioProcess International, I’ve copyedited thousands of articles. From business and regulatory discussions to technical reports and reviews, sponsored “advertorial” pieces, and beyond, I’ve seen it all in relation to the biopharmaceutical industry. Some papers, however, have stuck with me more than others, and one in particular comes to mind often lately.

Dec 12, 2024 | bioprocessintl.com | Cheryl Scott |Dana Cipriano |Brian Gazaille |Derek Ryan

Potency. Stability. Product characterization. Bioassays and other analytical methods provide a foundation of information on which biopharmaceutical development and manufacturing are built. Companies working with proteins, gene therapies, and other biological modalities are increasingly interested in taking a platform approach. They would love to have a set of go-to methods and protocols that can be applied across similar products in their portfolios.

Sep 1, 2024 | bioprocessintl.com | Cheryl Scott |Gigi Bat-Erdene |Jeff Fischer |Brian Gazaille

With the first half of 2024 now in the rearview mirror, I finally feel like I’m getting my feet under me as editor in chief ofBioProcess International. Since the first issue in January 2003, I’ve had the pleasure of helping BPI to establish itself as the leading publication and events brand for the global biopharmaceutical industry. And this September, all the BPI editors will attend our flagship conference and exhibition as part of the Biotech Week Boston festival.

Jul 31, 2024 | bioprocessintl.com | Cheryl Scott

Panelists Sam Chuang, Jesse McCool, and Ian Wyllie, with moderator Nicholas OstroutOn Wednesday afternoon, 5 June 2024, contract research organization (CRL) Charles River Laboratories (CRL) held a panel discussion as part of the BPI Theater at the Biotechnology Innovation Organization’s (BIO’s) annual convention in San Diego, CA.

Jul 31, 2024 | bioprocessintl.com | Cheryl Scott

Left to right, panelists Heikki Jouttijärvi, Adam Haskett, David Fontana, and Brad Stewart, with moderator Stephen Orosz. On Tuesday afternoon, 4 June 2024, consultants from BDO USA brought together a panel of leaders from up-and-coming biopharmaceutical companies to examine “make or buy” decision-making for manufacturing of advanced therapies.